Pristiq Dosage: Why 50 mg Is Usually Enough and When It's Not
Reviewed byDaniel Montville, MD, Psychiatrist
Siggy Clinical Team · Last updated September 24, 2026
Key Takeaways
- The recommended Pristiq dose is 50 mg once a day, and the label calls it both the starting dose and the therapeutic dose.
- Trials tested doses from 50 to 400 mg a day. All worked better than placebo, but doses above 50 mg added no extra benefit and caused more side effects and dropouts.
- At 50 mg, 4.1% of people stopped Pristiq because of side effects, close to the 3.8% rate on placebo. At 100 mg, that rate roughly doubled to 8.7%.
- If 50 mg isn't working, a higher dose is rarely the best next step. Time, a closer look at the diagnosis and side effects, or a different medication strategy often matter more.
If you’ve been on Pristiq 50 mg for a month and still feel flat, doubling the dose can seem like the obvious next move. For most people, the research suggests that move adds side effects faster than it adds relief.
Your brain responds to a medication up to a point, and then it stops responding much more. Desvenlafaxine, the drug in Pristiq, blocks the recycling of serotonin and norepinephrine, two chemical messengers tied to mood and energy. It’s also the main active form of venlafaxine (Effexor) after your body processes it, according to the Pristiq prescribing information. Good dosing means finding, with precision, the point where more drug stops adding benefit.
The standard dose is well chosen. The label recommends 50 mg once daily and calls it both the starting dose and the therapeutic dose. Pristiq’s effectiveness for depression was established in four 8-week trials of 50 to 400 mg a day, and two longer maintenance trials showed it helped prevent relapse. The evidence is solid, and the starting dose is well supported.
But “50 mg is the right dose” is only half an answer when you still don’t feel better, and at Siggy we think you deserve the reasoning behind the number as well as the number itself. This guide explains what the trials comparing doses found, why higher doses rarely help, when a prescriber might still change the dose, and what to consider if 50 mg isn’t enough. It starts with the shape of the dose-response curve.
What This Page Covers
- What the Pristiq Label Recommends
- What a Flat Dose-Response Curve Means
- What Trials Found When They Compared Doses
- Pristiq Doses at a Glance
- Why Higher Doses Cost More Than They Give
- When a Prescriber Might Change Your Dose
- What to Do If 50 mg Isn’t Working
- How Siggy Thinks About Dose Decisions
What the Pristiq Label Recommends
Pristiq is a serotonin and norepinephrine reuptake inhibitor, or SNRI, approved for major depressive disorder in adults. It comes as extended-release tablets in 25, 50, and 100 mg strengths.
The label’s instructions are simple. Take 50 mg once a day at about the same time, with or without food. Swallow the tablet whole, because the label says it shouldn’t be divided, crushed, chewed, or dissolved. There’s no build-up period: you start at the dose you’re meant to stay on.
The label also explains why it stops there. Trials studied doses from 10 to 400 mg a day, and doses from 50 to 400 mg worked, but no additional benefit showed up above 50 mg, while side effects and dropouts became more frequent at higher doses.
What a Flat Dose-Response Curve Means
A dose-response curve shows how much benefit you get as the dose goes up. For many antidepressants, that curve rises at first and then levels off, while side effects keep climbing.
A 2019 dose-response meta-analysis of 77 trials with 19,364 people showed this pattern clearly for SSRIs. Benefit rose up to a moderate dose and then flattened, while dropouts from side effects rose steeply across the whole range. The authors concluded that the lower part of the licensed dose range gave the best balance of benefit and tolerability.
That analysis didn’t include Pristiq, and venlafaxine, Pristiq’s parent drug, showed a more modest continued rise at higher doses. For Pristiq itself, the trials that compared doses head to head are the more direct evidence.
What Trials Found When They Compared Doses
The direct comparisons point the same way. In the label’s summary of studies comparing 50 mg and 100 mg a day, there was no suggestion of a greater effect with the higher dose, and side effects and discontinuations were more frequent at 100 mg.
A pooled analysis of three trials with 1,388 people put numbers on it. Depression scores dropped by 11.5 points on 50 mg and 11.8 points on 100 mg, compared with 9.6 points on placebo. Both doses worked, and the difference between them was small.
Other outcomes looked similar. A pooled analysis of nine trials found that Pristiq improved work, social, and family functioning compared with placebo, with no evidence of a dose-response relationship across 50 to 400 mg. Both analyses drew on manufacturer-sponsored trials, which is common in drug research and worth knowing.
Pristiq Doses at a Glance
The table below summarizes how the Pristiq prescribing information describes each dose level.
| Dose | Main Use | What the Label Says |
|---|---|---|
| 25 mg daily | Tapering, severe kidney impairment | Intended for gradual dose reduction |
| 50 mg daily | Standard starting and target dose | Recommended dose for most adults |
| 100 mg daily | Studied in trials | No added benefit, more dropouts than 50 mg |
| 200 to 400 mg daily | Studied in trials | Effective, but more side effects |
Why Higher Doses Cost More Than They Give
Side effects are the clearest cost. In the Pristiq label’s pooled trials, which lasted 8 weeks, 4.1% of people on 50 mg stopped because of side effects, close to the 3.8% rate on placebo. At 100 mg, that rate rose to 8.7%. Nausea was the most common side effect leading people to stop.
Blood pressure is another. The label reports that Pristiq was linked to sustained high blood pressure at every dose studied, with a suggestion of a higher rate at 400 mg, and it recommends checking blood pressure regularly during treatment.
Drug interactions grow with dose, too. Pristiq raises levels of some medications processed by the liver enzyme CYP2D6. In a label study, 100 mg of Pristiq raised levels of the CYP2D6 test drug desipramine by about 17%, while 400 mg raised them by about 90%.
“When side effects start, you’re on your own until the next appointment.” That feeling is common, and it’s one reason a dose increase that brings new side effects without new benefit can quietly push people to stop treatment altogether.
When a Prescriber Might Change Your Dose
There are real reasons to use a dose other than 50 mg, and most of them point lower. Pristiq is cleared largely through the kidneys, so kidney function matters:
- Moderate kidney impairment: the label caps the dose at 50 mg a day.
- Severe kidney impairment or end-stage kidney disease: 25 mg daily or 50 mg every other day.
- Moderate to severe liver impairment: 50 mg a day, with doses above 100 mg not recommended.
- Stopping treatment: the 25 mg tablet exists to make a gradual taper possible.
Older adults deserve extra care as well. In the label’s trials, a sharp drop in blood pressure on standing occurred in 8% of people 65 and older on Pristiq, compared with 2.5% on placebo, and the label notes that reduced kidney clearance should be considered when choosing a dose.
Some prescribers do try 100 mg when 50 mg gives only a partial response. That’s a clinical judgment call, and the label’s data suggest weighing it against the higher rate of side effects. For how prescribers think through dose changes for a different antidepressant, our guide to how doctors decide on Lexapro dosage walks through a similar decision.
What to Do If 50 mg Isn’t Working
A higher dose feels like the natural fix, but the evidence for dose increases is thin. A meta-analysis of nine randomized trials with 1,273 people found that raising the dose of an SSRI after it failed worked no better than staying on the same dose. The authors noted that SNRIs like Pristiq haven’t been studied enough in this situation to know for sure.
These steps are usually more useful:
- Give it time. Judge Pristiq after several weeks at a steady dose rather than a few days.
- Take it consistently, at about the same time every day.
- Track what’s changing, including sleep, energy, and side effects, and share it with your prescriber.
- Ask whether something else is in the way, like poor sleep, alcohol, another medical condition, or a diagnosis that needs a second look.
- Discuss other strategies, such as switching medications, adding therapy, or adding another treatment, if Pristiq still isn’t helping.
Don’t raise, lower, or stop your dose on your own. If you decide to stop, the label recommends a gradual reduction, because stopping abruptly can cause discontinuation symptoms.
Pristiq carries a boxed warning about suicidal thoughts and behaviors in children, teens, and young adults. If you have thoughts of harming yourself, or you notice sudden agitation, panic, or unusual mood changes, call 911 or the 988 Suicide and Crisis Lifeline right away.
How Siggy Thinks About Dose Decisions
A dose decision is only as good as the information behind it. When the only data point is how you feel on the day of a quarterly visit, “go up to 100” can look like progress even when it isn’t.
Siggy’s care currently centers on SSRI-based treatment for anxiety and depression, so Siggy doesn’t manage Pristiq. What carries over is the principle behind this guide: more medication is not the same as better treatment, and dose changes should follow what’s actually happening between visits. If you’re weighing medication classes, our comparison of SNRIs and SSRIs explains how prescribers choose, and our overview of Pristiq for depression covers the basics.
For most people, 50 mg of Pristiq is the dose that works, and going higher mainly adds side effects. If you’re considering an SSRI-based plan for anxiety or depression, Siggy’s free, anonymous intake takes no name, email, or login, and you get a consult summary and a downloadable report you can share with any clinician.
Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.
This article is for education only and isn’t a substitute for personal medical advice. Talk with your own clinician before starting, changing, or stopping any medication.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
What is the normal dose of Pristiq?
The normal dose of Pristiq is 50 mg once a day, with or without food. The label describes 50 mg as both the starting dose and the therapeutic dose, so most people don't need to build up to it.
Is 100 mg of Pristiq better than 50 mg?
For most people, no. In trials that compared 50 mg and 100 mg directly, the higher dose showed no greater effect on depression, and the rate of people stopping because of side effects rose from 4.1% at 50 mg to 8.7% at 100 mg.
What is the maximum dose of Pristiq?
Clinical trials studied doses up to 400 mg a day, but the label says doses above 50 mg added no benefit and caused more side effects. For people with moderate to severe liver impairment, the label advises against going above 100 mg a day.
What is the 25 mg Pristiq tablet for?
The 25 mg tablet is mainly for tapering, so you can step down gradually when stopping. It's also the daily dose the label lists for people with severe kidney impairment or end-stage kidney disease.
Can you cut Pristiq in half?
No. Pristiq is an extended-release tablet, and the label says it must be swallowed whole and not divided, crushed, chewed, or dissolved. If you need a different dose, ask your prescriber about the 25 mg tablet.
What should I do if Pristiq 50 mg isn't working?
Talk with your prescriber before changing anything. Give it enough time, usually several weeks at a steady dose, then review side effects, sleep, other conditions, and whether a different medication or added treatment makes more sense than a higher Pristiq dose.
Sources
- DailyMed. Pristiq (desvenlafaxine extended-release tablets) Prescribing Information. Pfizer. U.S. National Library of Medicine. dailymed.nlm.nih.gov
- Furukawa TA, Cipriani A, Cowen PJ, et al. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. The Lancet Psychiatry. 2019;6(7):601-609. doi:10.1016/S2215-0366(19)30217-2
- Tourian KA, Padmanabhan SK, Groark J, et al. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies. Clinical Therapeutics. 2009;31(Pt 1):1405-1423. doi:10.1016/j.clinthera.2009.07.006
- Soares CN, Kornstein SG, Thase ME, et al. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials. Journal of Clinical Psychiatry. 2009;70(10):1365-1371. doi:10.4088/JCP.09m05133blu
- Rink L, Braun C, Bschor T, et al. Dose increase versus unchanged continuation of antidepressants after initial antidepressant treatment failure in patients with major depressive disorder: a systematic review and meta-analysis of randomized, double-blind trials. Journal of Clinical Psychiatry. 2018;79(3):17r11693. doi:10.4088/JCP.17r11693